Therapeutic Failures of Antibiotics Used To Treat Macrolide-Susceptible Streptococcus pyogenes Infections May Be Due to Biofilm Formation
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Streptococcus pyogenes infections often fail to respond to antibiotic therapy, leading to persistent throat carriage and recurrent infections. Such failures cannot always be explained by the occurrence of antibiotic resistance determinants, and it has been suggested that S. pyogenes may enter epithelial cells to escape antibiotic treatment. We investigated 289 S. pyogenes strains isolated from different clinical sources to evaluate their ability to form biofilm as an alternative method to escape antibiotic treatment and host defenses. Up to 90% of S. pyogenes isolates, from both invasive and noninvasive infections, were able to form biofilm. Specific emm types, such as emm 6, appeared to be more likely to produce biofilm, although variations within strains belonging to the same type might suggest biofilm formation to be a trait of individual strains rather than a general attribute of a serotype. Interestingly, erythromycin-susceptible isolates formed a significantly thicker biofilm than resistant isolates ( P < 0.05). Among resistant strains, those carrying the erm class determinants formed a less organized biofilm than the mef (A)-positive strains. Also, prtF1 appeared to be negatively associated with the ability to form biofilm ( P < 0.01). Preliminary data on a selection of strains indicated that biofilm-forming isolates entered epithelial cells with significantly lower efficiency than biofilm-negative strains. We suggest that prtF1 -negative macrolide-susceptible or mef (A)-carrying isolates, which are poorly equipped to enter cells, may use biofilm to escape antimicrobial treatments and survive within the host. In this view, biofilm formation by S. pyogenes could be responsible for unexplained treatment failures and recurrences due to susceptible microorganisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 1×
“Biofilm is known to provide microorganisms with greater resistance to antibiotic treatment and to host immunity ( 15 ).”
BackgroundBiofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00797.x · Cited by 2,537 · cited 2×
“Parallel measurements of biofilm formation were performed both as described in Materials and Methods and by applying the modification suggested by O’Toole and Kolter (33) to the original protocol described by Christensen et al.”
Method
Cited by
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
“It has been suggested that GAS may escape penicillin treatment by entering epithelial cells, which are poorly penetrated by penicillin (475–477), or by forming a biofilm (478, 479), or alternatively, failure of penicillin treatment may possibly be due to the protection of GAS by other -lactamase-producing bacterial sp…”
BackgroundDelivery of antibiotics with polymeric particles
Xiong, M.-H., Bao, Y., Yang, X.-Z., Zhu, Y.-H., & Wang, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.002 · Cited by 302
Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation
Manetti, A. G. O., Zingaretti, C., Falugi, F., Capo, S., Bombaci, M., Bagnoli, F., Gambellini, G., Bensi, G., Mora, M., Edwards, A. M., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05704.x · Cited by 248
“In addition, a role for biofilms in GAS pathogenesis has recently been proposed and experimentally supported in a number of recent publications (Neely et al., 2002; Akiyama et al., 2003; Hidalgo-Grass et al., 2004; Cho and Caparon, 2005; Baldassarri et al., 2006).”
BackgroundKalpana, B. J., Aarthy, S., & Pandian, S. K. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-011-9526-2 · Cited by 173
Thenmozhi, R., Nithyanand, P., Rathna, J., & Karutha Pandian, S. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00613.x · Cited by 173
Connolly, K. L., Roberts, A. L., Holder, R. C., & Reid, S. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018984 · Cited by 77
Bacterial biofilm in upper respiratory tract infections
Morris, D. P. (2007) · Current Infectious Disease Reports · doi:10.1007/s11908-007-0030-3 · Cited by 37
Metadata
- Authors
- Baldassarri, L., Creti, R., Recchia, S., Imperi, M., Facinelli, B., Giovanetti, E., Pataracchia, M., Alfarone, G., & Orefici, G.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2006-08
- Volume
- 44
- Issue
- 8
- Pages
- 2721-2727
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2171783565
- Cited by
- 140
- References
- 3
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.